MGIS: managing banana (Musa spp.) genetic resources information and high-throughput genotyping data.

Database URL: https://www.crop-diversity.org/mgis/.

Splenic embolization in liver transplant recipients: early outcomes.

Clinical improvement has been reported following splenic embolization for a wide variety of indications. Improvement following splenic embolization has been described in cirrhotic patients awaiting hepatic transplantation who are not candidates for surgical splenectomy. Occasionally, patients who have undergone hepatic transplantation have conditions that may also benefit from nonsurgical intervention with splenic embolization. Indications include persistent hypersplenism and pancytopenia precluding optimal treatment with antiviral therapy or chemotherapy, risk for persistent gastroesophageal variceal hemorrhage, and splenic artery steal syndrome attenuating hepatic arterial perfusion. Limited data is available on the outcome of splenic embolization in liver transplant recipients. We present the early outcomes of liver transplant recipients who were treated with splenic embolization. A retrospective chart review of all liver transplant recipients who underwent splenic embolization between 1997 and 2006 was performed, under minimal-risk study approval by the institutional review board. Five liver transplant recipients received splenic embolization: 3 for persistent hypersplenism, 1 for increased risk of gastroesophageal variceal hemorrhage, and 1 for splenic artery steal syndrome. The patients with hypersplenism demonstrated hematologic improvement, the patient with gastroesophageal varices did not experience any hemorrhage on follow-up, and the patient with splenic artery steal experienced resolution of the steal phenomenon. Postembolization syndrome was observed but no splenic abscess or death occurred. Mean follow-up was 20.2 months. In conclusion, splenic embolization is a safe and effective nonsurgical alternative for a variety of indications in liver transplant recipients.

First Report of Burkholderia cepacia as a Pathogen of Banana Finger-Tip Rot in Taiwan.

Banana finger-tip rot is an endemic minor disease in Taiwan. Diseased fingers are recognized externally by their distorted shape, often being narrow at the tip, smaller, and curved out of line with the other fingers. Parts of the pulp within the finger appear slightly gelatinous and yellow. Frequently, a brown discoloration is evident at the tip of the flower end. Although Pseudomonas sp. was reported to be a causal pathogen, the identity of the species was not determined (1). Isolations from diseased fingers consistently yielded bacterial colonies that were whitish-yellow on Luria-Bertani agar and did not produce fluorescent pigment on King's medium B. Three isolates were selected for further characterization. All isolates were gram negative, aerobic, and grew at 42°C, positive for oxidase, lysine decarboxylase, and ornithine decarboxylase, but negative for arginine dihydrolase and tryptophanase (indole production). The isolates hydrolyzed gelatin and esculin, produced acids by utilizing d (+)-glucose, mannose, sucrose, maltose, d-mannitol, d-sorbitol, and dulcitol, but not melibiose, or rhamnose. The isolates caused rotting symptom on onion that was more severe than on potato and carrot slices. The bacterium was identified as Burkholderia cepacia. Almost complete 16S rDNA sequence (1,489 bp; GenBank Accession No. AY207313) of one isolate (strain B9) was determined and compared with available 16S rDNA sequences of members of B. cepacia complex. The sequence was similar (99.87%) to that of B. cepacia genomovar III LMG 12614 (GenBank Accession No. AF097532). Bacterial suspensions (108 CFU/ml) were injected through the center of the stigma, and the fingers were enclosed in a plastic bag to maintain high humidity. Twenty fingers (three to four fingers in each hand) were inoculated totally. A majority (80%) of the wound inoculations were successful, and typical symptoms appeared in 10 to 14 days. Control plants were inoculated with sterile distilled water. A small amount (2 to 5%) of control plants also showed symptoms. This may result from finger infestation with epiphytic or endophytic B. cepacia. Young fruits were more susceptible than older fruits. The bacterium was readily reisolated from diseased fingers and confirmed as B. cepacia. To our knowledge, this is the first report of B. cepacia as a causal pathogen of banana finger-tip rot. Reference: (1) I. W. Buddenhagen. Plant Prot. Bull. 16:17, 1968.

Needle localization in MR-guided biopsy and aspiration: effects of field strength, sequence design, and magnetic field orientation.

OBJECTIVE: The purpose of this investigation was to evaluate the accuracy of MR Imaging for needle depiction at 0.2 and 1.5 T with multiple pulse sequences and needle orientations. The goal was to provide a framework for biopsy approach and imaging technique parameter selection that will ensure the safety and accuracy of MR-guided procedures. MATERIALS AND METHODS: Eight titanium and stainless steel alloy MR-compatible biopsy devices were immersed in fluid phantoms and placed into 1.5- and 0.2-T MR systems used for clinical imaging. Spin-echo, turbo spin-echo, and gradient-echo images were obtained with the needle shafts of the biopsy devices placed parallel to, perpendicular to, and at angles of 30 degrees and 60 degrees relative to the static magnetic field of the scanner. All images were obtained with the frequency-encoding direction parallel to and perpendicular to the needle shaft. Needle width and tip position were measured from images on a freestanding workstation, and the apparent tip position was compared with that obtained by direct measurement. The difference between these values was calculated for each needle type, imaging sequence, frequency-encoding direction, and needle orientation. RESULTS: Artifactual widening was much more apparent at 1.5 T than at 0.2 T, as was error in determining needle tip position. Artifacts at both field strengths were most pronounced with gradient-echo sequences, less so with turbo spin-echo sequences, and least of all with spin-echo sequences. For spin-echo and turbo spin-echo sequences, when the frequency-encoding axis was perpendicular to the needle shaft, the apparent width of the needle was larger, but error in needle tip position was smaller. Artifacts were much less apparent, but error in tip position increased, as the orientation of the needle shaft became more parallel to the direction of the magnetic field. CONCLUSION: Specific measurements differed with field strength, but needle tip localization within 1 mm was obtained at both 0.2 and 1.5 T with the appropriate frequency-encoding direction, pulse sequence, and imaging parameters. Orientation of the needle parallel to the magnetic field significantly reduced the apparent width of the needle at both field strengths but also decreased the accuracy of needle tip position localization.

Sphingosine-mediated phosphatidylinositol metabolism and calcium mobilization.

The cytokine-mediated stimulation of sphingomyelin (SM) metabolism is emerging as an important signal transduction pathway via the generation of ceramide and sphingosine, products which have been shown to affect a wide variety of biological processes. Because SM-mediated signal transduction is initiated via the hydrolysis of an integral membrane phospholipid by a phospholipase C-like enzyme (sphingomyelinase) to yield lipids which modulate protein kinase C activity, the SM and phosphatidylinositol (PI) signaling pathways share certain similarities. The present study was undertaken to examine the potential for interplay between SM and PI turnover by testing the effects of sphingosine, sphingosine-1-phosphate, and ceramide on PI turnover. In dermal fibroblasts, sphingosine stimulated a rapid dose-dependent hydrolysis of PI, yielding inositol 1,4,5-triphosphate, followed by increased levels of intracellular calcium. Sphingosine-induced inositol phosphate (IP) accumulation was observed between 5 and 30 microM sphingosine with a maximal accumulation of 2.7-fold over control levels. Enhanced IP formation was measured as early as 5 s following sphingosine treatment and IP levels remained elevated for more than 60 min. Intracellular calcium mobilization accompanied the dose-dependent accumulation of IPs in response to sphingosine, although this effect was not apparent until after a 30-40-s lag period. Interestingly, sphingosine-1-phosphate stimulated a more rapid release of intracellular Ca2+ than sphingosine, but it had no effect on PI turnover. DL-threo-Dihydrosphingosine, a competitive inhibitor of sphingosine kinase, stimulates both PI turnover and Ca2+ flux, but does not block the action of sphingosine relative to those two processes. Ceramide (added as C2-ceramide), N-stearylamine, and stearoyl-D-sphingosine did not affect PI turnover or Ca2+ mobilization. Pretreatment of intact cells with pertussis toxin partially inhibited sphingosine-mediated IP accumulation, suggesting a role for guanine nucleotide binding protein(s) (G protein) in sphingosine-stimulated PI turnover. Furthermore, guanosine 5'-O-(3-thiotriphosphate) stimulated, whereas guanosine 5'-O-(2-thiodiphosphate) inhibited, sphingosine-induced IP accumulation in permeabilized cells. Collectively, these data suggest that sphingosine enhances PI turnover by stimulating phospholipase C activity, and the activation of this process may be modulated by G protein interactions. Thus, the regulation of PI turnover and Ca2+ mobilization by sphingosine may represent another mechanism by which sphingosine modulates cell function and that these effects can be distinguished from those of ceramide.

Interleukin-1-mediated PGE2 production and sphingomyelin metabolism. Evidence for the regulation of cyclooxygenase gene expression by sphingosine and ceramide.

We recently demonstrated that sphingosine enhances interleukin-1 beta (IL-1)-mediated prostaglandin E2 (PGE2) production in human dermal fibroblasts (Ballou, L. R., Barker, S. C., Postlethwaite, A. E., and Kang, A. H. (1990) J. Immunol. 145, 4245-4251). Because sphingosine and ceramide are interconvertable, we extended previous studies by treating cells with C2-ceramide (C2-cer), a membrane-soluble analogue of ceramide, and found that C2-cer stimulates IL-1-mediated PGE2 production to the same degree as sphingosine. In an effort to elucidate the mechanistic basis by which sphingosine and C2-cer affect PGE2 production, we examined the effect of these molecules on the expression of genes encoding cyclooxygenase (EC 1.14.99.1, Cox) and phospholipase A2 (EC 3.1.1.4, PLA2), the rate-limiting enzymes in PGE2 biosynthesis. We found that sphingosine and C2-cer treatment resulted in an 8-fold induction of Cox mRNA within 1-2 h which declined thereafter; concomitant changes in Cox protein were also observed. In contrast, expression of phospholipase A2 remained unaltered. We also found that IL-1-mediated PGE2 production was dramatically enhanced in cells treated simultaneously with sphingomyelinase which led us to directly test the effect of IL-1 on sphingomyelin turnover. IL-1 treatment induced the hydrolysis of a significant fraction of prelabeled sphingomyelin which was accompanied by increased levels of intracellular ceramide. Taken together, our results suggest that enhanced Cox expression may account for the observed enhancement of IL-1-mediated PGE2 production by sphingosine and C2-cer. These data also suggest that endogenous sphingomyelin metabolites, generated in response to IL-1, may play an important role in IL-1 signal transduction.